経カテーテル心臓弁置換術の世界市場規模、シェア、成長分析：製品別、手術アプローチ別、最終用途別、用途別、地域別 - 産業予測（2024年～2031年）

世界の経カテーテル心臓弁置換術の市場規模は、2022年に58億米ドルと評価され、2023年の66億7,000万米ドルから2031年には204億米ドルに成長し、予測期間中（2024年～2031年）のCAGRは15.0％で成長する見通しです。

世界の経カテーテル心臓弁置換術（TAVR）市場は、重度の大動脈弁疾患を患う患者にとって、従来の開心術に代わる低侵襲手術として好まれるようになり、大きな成長を遂げています。この革新的な治療法は、カテーテル治療による人工弁の移植を可能にし、手術リスク、入院期間、回復時間を最小限に抑えるため、特にリスクの高い患者や手術不可能な患者にとって有益です。成長の原動力には、技術的進歩、患者層の拡大、医療提供者の間での受け入れ拡大などがあり、高齢者人口の増加や心血管疾患の急増によってさらに拍車がかかっています。研究開発への継続的な投資は、弁設計と画像技術を向上させ、手術結果の改善を確実にすることを目的としています。医療機器メーカーとヘルスケア利害関係者の協力関係が強化されるにつれて、TAVR市場は持続的拡大の態勢を整え、患者の転帰と心血管系の状況を大幅に改善します。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次・一次情報源
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2023年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析

経カテーテル心臓弁置換術市場規模：製品別、CAGR（2024年～2031年）

• 市場概要
• 経カテーテル肺動脈弁置換術
• 経カテーテル僧帽弁修復および置換
• 経カテーテル大動脈弁置換術

経カテーテル心臓弁置換術市場規模：手術アプローチ別、CAGR（2024年～2031年）

• 市場概要
• 経心尖アプローチ
• 経大腿アプローチ
• その他

経カテーテル心臓弁置換術市場規模：最終用途別、CAGR（2024年～2031年）

• 市場概要
• カテーテルラボ
• 病院

経カテーテル心臓弁置換術市場規模：用途別、CAGR（2024年～2031年）

• 市場概要
• 肺動脈弁疾患
• 僧帽弁疾患
• 大動脈弁疾患

経カテーテル心臓弁置換術市場規模、CAGR（2024年～2031年）

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州
• アジア太平洋
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2023年）
• 主な市場企業が採用した戦略
• 市場の最近の動向
• 企業の市場シェア分析（2023年）
• 主要企業プロファイル
  • 会社概要
  • 製品ポートフォリオ分析
  • セグメント別シェア分析
  • 収益の前年比の比較（2021年～2023年）

主要企業プロファイル

• Edwards Lifesciences Corporation（USA）
• Medtronic plc（Ireland）
• Boston Scientific Corporation（USA）
• Abbott Laboratories（USA）
• JenaValve Technology, Inc.（USA）
• SYMETIS（Switzerland）
• Braile Biomedica（Brazil）
• CryoLife, Inc.（USA）
• Micro Interventional Devices, Inc.（USA）
• LivaNova PLC（UK）
• Meril Life Sciences Pvt. Ltd.（India）
• Venus Medtech（Hangzhou）Inc.（China）
• Suzhou Jiecheng Medical Technology Co. Ltd.（China）
• Peijia Medical Limited（China）
• Blue Sail Medical Co., Ltd.（China）
• Colibri Heart Valve LLC（USA）
• HighLife SAS（France）
• Neovasc Inc.（Canada）
• St. Jude Medical, Inc.（USA）

結論と推奨事項

Global Transcatheter Heart Valve Replacement Market size was valued at USD 5.8 billion in 2022 and is poised to grow from USD 6.67 billion in 2023 to USD 20.4 billion by 2031, growing at a CAGR of 15.0% during the forecast period (2024-2031).

The global transcatheter heart valve replacement (TAVR) market is experiencing significant growth as it emerges as a preferred minimally invasive alternative to traditional open-heart surgery for patients suffering from severe aortic valve disease. This innovative procedure allows for the implantation of prosthetic valves through catheterization, minimizing surgical risks, hospital stays, and recovery times, making it particularly beneficial for high-risk or inoperable patients. Growth drivers include technological advancements, a larger patient demographic, and increased acceptance among healthcare providers, exacerbated by a growing aging population and a surge in cardiovascular conditions. Ongoing investment in research and development aims to enhance valve designs and imaging techniques, ensuring improved procedural outcomes. As collaborations between medical device manufacturers and healthcare stakeholders strengthen, the TAVR market is poised for sustained expansion, significantly improving patient outcomes and the cardiovascular landscape.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Transcatheter Heart Valve Replacement market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Transcatheter Heart Valve Replacement Market Segmental Analysis

Global Transcatheter Heart Valve Replacement Market is segmented by product, surgical approach, end-use, application and region. Based on product, the market is segmented into transcatheter pulmonary valve replacement, transcatheter mitral valve repair & replacement and transcatheter aortic valve replacement. Based on surgical approach, the market is segmented into transapical approach, transfemoral approach and others. Based on end-use, the market is segmented into cath labs and hospitals. Based on application, the market is segmented into pulmonary valvular heart disease, mitral valvular heart disease and aortic valvular heart disease. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Transcatheter Heart Valve Replacement Market

The Transcatheter Heart Valve Replacement (THVR) market is significantly influenced by the aging global population and the growing prevalence of heart disease. As individuals age, the incidence of heart valve diseases, particularly conditions like aortic stenosis, is on the rise, which in turn escalates the demand for THVR procedures. With longer life expectancies, more patients are likely to experience valve-related complications, resulting in an expanding market for innovative heart valve replacement solutions. This demographic trend, coupled with the increasing recognition of THVR's benefits over traditional surgical methods, is propelling the market forward, creating opportunities for advancements in medical technology and patient care.

Restraints in the Global Transcatheter Heart Valve Replacement Market

The Global Transcatheter Heart Valve Replacement (THVR) market faces several restraints, notably the high initial costs linked with the procedures. These expenses encompass not only the devices but also the required specialized equipment, making it a significant financial burden. Furthermore, reimbursement issues and inconsistent healthcare policies across various regions can create barriers that limit patient access to these advanced treatments. These financial and policy-related challenges may subsequently impede the overall growth and expansion of the market, as they affect both patient affordability and healthcare provider willingness to adopt THVR solutions in their practices.

Market Trends of the Global Transcatheter Heart Valve Replacement Market

The Global Transcatheter Heart Valve Replacement (THVR) market is experiencing significant growth, fueled by rapid technological advancements and an increasing preference for minimally invasive procedures. Cutting-edge innovations, including enhanced valve designs, state-of-the-art imaging techniques, and novel delivery systems, are revolutionizing the field, making procedures safer and more effective. This trend is not only reducing complications but also broadening the spectrum of patients eligible for treatment. Consequently, more healthcare providers are recognizing THVR as a preferred solution for aortic valve diseases, contributing to its expanded adoption and solidifying its position as a critical component of cardiac care worldwide.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2023
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Transcatheter Heart Valve Replacement Market Size by Product & CAGR (2024-2031)

• Market Overview
• Transcatheter Pulmonary Valve Replacement
• Transcatheter Mitral Valve Repair & Replacement
• Transcatheter Aortic Valve Replacement

Global Transcatheter Heart Valve Replacement Market Size by Surgical Approach & CAGR (2024-2031)

• Market Overview
• Transapical Approach
• Transfemoral Approach
• Others

Global Transcatheter Heart Valve Replacement Market Size by End-Use & CAGR (2024-2031)

• Market Overview
• Cath Labs
• Hospitals

Global Transcatheter Heart Valve Replacement Market Size by Application & CAGR (2024-2031)

• Market Overview
• Pulmonary Valvular Heart Disease
• Mitral Valvular Heart Disease
• Aortic Valvular Heart Disease

Global Transcatheter Heart Valve Replacement Market Size & CAGR (2024-2031)

• North America (Product, Surgical Approach, End-Use, Application)
  • US
  • Canada
• Europe (Product, Surgical Approach, End-Use, Application)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Surgical Approach, End-Use, Application)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Surgical Approach, End-Use, Application)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Surgical Approach, End-Use, Application)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2023
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• Edwards Lifesciences Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Scientific Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• JenaValve Technology, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SYMETIS (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Braile Biomedica (Brazil)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CryoLife, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Micro Interventional Devices, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LivaNova PLC (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Meril Life Sciences Pvt. Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Venus Medtech (Hangzhou) Inc. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Suzhou Jiecheng Medical Technology Co. Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Peijia Medical Limited (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Blue Sail Medical Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Colibri Heart Valve LLC (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• HighLife SAS (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Neovasc Inc. (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• St. Jude Medical, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations